STAT+: Work on mRNA therapies was surging. Now Kennedy has rocked the field
Companies in a burgeoning field of mRNA therapeutics express shock at HHS' deep cuts to research funding.
Previous Post
Hibernating for better health: harnessing the genetic mechanisms underlying hibernation
Next Post
Anchor It
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago